多囊卵巢综合征中的血清虹膜及其改变与美特福林干预的干预
Radhakrishna Telagareddy1, Padala Ravi Kumar1, Sudhi Ranjan Pattanaik1
1Department of Endocrinology, M.K.C.G Medical College, Berhampur, Odisha, India.
Indian journal of endocrinology and metabolism
|March 27, 2024
概括
在患有多囊性卵巢综合征 (PCOS) 的女性中,血清虹膜素水平升高. 在超重/肥胖的PCOS患者中,甲胺治疗显著降低了虹膜素,改善了胰岛素抵抗.
科学领域:
- 内分泌学 在内分泌学.
- 代谢综合征是代谢综合征的一种.
- 生殖健康 生殖健康
背景情况:
- 多囊卵巢综合征 (PCOS) 是一种复杂的内分泌疾病,与代谢功能障碍有关.
- 在PCOS患者中,血清里素水平及其对甲胺的反应仍然不完全理解.
- 相互矛盾的研究结果需要进一步调查伊丽素在PCOS中的作用.
研究的目的:
- 与对照人群相比,检查PCOS患者的血清虹膜素水平.
- 在6个月的时间内评估甲福明治疗对血清虹膜素水平的影响.
- 探索在PCOS中素水平,代谢参数和胰岛素抵抗之间的关联.
主要方法:
- 一项随机对照研究,涉及187名PCOS患者和94名年龄匹配的对照.
- 评估了人类测量,生化和荷尔蒙参数.
- 99名超重/肥胖的PCOS患者的小组仅接受甲福明 (每天500毫克三次) 或生活方式干预,在基线和6个月测量素水平.
主要成果:
- 血清虹膜素在PCOS患者中显著高于对照组 (12.47 vs 8.3 ng/ml,P < 0.001),无论BMI.
- 在超重/肥胖的PCOS患者中,虹膜素与BMI,腰比,LH,TG,FAI,和HOMA-IR正相关.
- 甲福明治疗显著降低了血清中位素水平 (13.9至12.1 ng/ml,P < 0.001),这种变化与HOMA-IR有关.
结论:
- 血清里素的升高是PCOS的一个特征,独立于BMI.
- 在超重/肥胖的PCOS患者中,甲福明治疗有效降低血清里素水平.
- 与甲胺一起降低虹膜素的含量与胰岛素抵抗的改善有关.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Hormonal Regulation of the Menstrual Cycle
354
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
354
Infertility in Females
292
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
292


